当前位置: 首页 > 期刊 > 《健康前沿》 > 20198
编号:13555253
铁调素抗乙型肝炎病毒活性的初步研究(2)
http://www.100md.com 2019年4月15日 《健康前沿》 20198
     基金:安徽省科技厅重点研究与开发计划项目(1804h08020236);安徽省高校自然科学研究项目(KJ2018A0206);安徽医科大学第二附属医院首批“火花计划”科研项目(2015hhjh06)

    参考文献:

    [1]Sow FB,Florence WC,Satoskar AR,Schlesinger LS,Zwilling BS,Lafuse WP. Expression and localization of hepcidin in macrophages:a role in host defense against tuberculosis. Journal of LeukocyteBiology. 2007;82(4):934–45.

    [2]Peyssonnaux C,Zinkernagel AS,Datta V,Lauth X,Johnson RS,Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107(9):3727–32.

    [3]Hunter HN,Fulton DB,Ganz T,Vogel HJ. The solution structure of human hepcidin,apeptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. Journal of Biological Chemistry. 2002;277(40):37597–603.

    [4] Lambrecht RW,Sterling RK,Naishadham D,Stoddard AM,Rogers T,Morishima C,et al. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011;140(5):1490–500.

    [5] Liu H,Trinh T L,Dong H,et al. Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus. PLoS ONE,2012,7(10):e46631.

    作者簡介:

    王兆飞,男,硕士研究生;单位:安徽医科大学第二附属医院 检验科,合肥230601

    管世鹤,男,教授,主任技师,博士生导师,责任作者,单位:安徽医科大学第二附属医院 检验科,合肥230601,E-mail:shiheguan@126.com。, 百拇医药(王兆飞 管世鹤 陈礼文 杨凯 张浩 候舒文 潘正兰 段元丽 王秀)
上一页1 2